Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Demis Hassabis, chief of Google DeepMind, believes there's a 50% chance of achieving AGI within 5 years. AGI means ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling breakthroughs. Brands. ... which emerged from Google DeepMind in 2021, ...

Google has announced the consolidation of its formerly separate AI research labs — Google Brain and DeepMind — into a new unit named Google DeepMind. The new team will spearhead groundbreaking ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. ... We develop those, put them into human clinical trials… we haven’t got that yet, ...

DeepMind boss Demis Hassabis believes AI as smart as humans might not be far off. Hassabis is at the forefront of the Google-owned AI lab's efforts to develop AGI. He made the comments at a Wall ...

Google formed Google DeepMind a year ago by combining two research teams in the AI field — the Brain Team of Google Research, and DeepMind. This focused team, backed by the computational prowess ...

Google's artificial intelligence company DeepMind has developed a breakthrough AI system that learns in a similar way to a human in order to prevent "catastrophic forgetting." ...

How Google DeepMind's ant soccer skills can help improve your search results; Google DeepMind wins again: AI trounces human expert in lip-reading face-off; Google's DeepMind AI: Now it taps into ...